CollPlant Biotechnologies Ltd. (CLGN)Healthcare | Biotechnology | Rehovot, Israel | NasdaqCM
0.36 USD
+0.00
(1.334%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 0.36 +0.00 (0.840%) ⇧ (April 17, 2026, 6:05 p.m. EDT) Short-term: ★☆☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 1:14 p.m. EDT
CLGN is currently trading at a significant discount to its 52-week high and is experiencing substantial volatility. The recent price history shows a downward trend, with the stock trading near its 52-week low. The fundamental data indicates poor financial health, with negative earnings, low revenue growth, and high debt-to-equity ratios. The options market shows mixed signals, with OTM calls indicating potential upside speculation and OTM puts indicating some bearish sentiment. However, the current price is far from the strike prices, making the options activity less reliable. Dividend yields are non-existent, and the stock is not a strong candidate for dividend investors. Given the poor fundamentals and the lack of clear momentum, CLGN is not a suitable investment for short-term or long-term investors at this time. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 1.017048 |
| AutoETS | 1.129966 |
| AutoARIMA | 1.129970 |
| MSTL | 1.134817 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 34% |
| H-stat | 2.33 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 1.62 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 46.802 |
| Revenue per Share | 0.194 |
| Market Cap | 5,146,200 |
| Forward P/E | -0.92 |
| Beta | 0.94 |
| Website | https://collplant.com |
As of April 11, 2026, 1:14 p.m. EDT: Options speculators are predominantly buying out-of-the-money (OTM) calls and puts, with significant open interest in OTM calls, especially for the 2026-04-17 and 2026-07-17 expirations. The high IV (implied volatility) for OTM calls suggests speculation on potential upward movement, although the current price is far below these strike prices. The presence of OTM puts with high open interest indicates some bearish sentiment, but the low IV for puts suggests less conviction in a downward move. Overall, the options activity suggests mixed signals, with a slight bias toward potential upside, but the current price is far from these strike prices, making the outlook uncertain.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.8480851 |
| Address1 | Weizmann Science Park |
| Address2 | 4 Oppenheimer P.O. Box 4132 |
| All Time High | 24.26 |
| All Time Low | 0.271 |
| Ask | 0.475 |
| Ask Size | 1 |
| Average Analyst Rating | 3.0 - Hold |
| Average Daily Volume10 Day | 213,750 |
| Average Daily Volume3 Month | 110,750 |
| Average Volume | 110,750 |
| Average Volume10Days | 213,750 |
| Beta | 0.939 |
| Bid | 0.6105 |
| Bid Size | 1 |
| Book Value | 0.475 |
| City | Rehovot |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Israel |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.357 |
| Current Ratio | 2.525 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 0.4138 |
| Day Low | 0.3301 |
| Debt To Equity | 46.802 |
| Display Name | CollPlant Biotechnologies |
| Dividend Date | 1,479,686,400 |
| Earnings Call Timestamp End | 1,742,997,600 |
| Earnings Call Timestamp Start | 1,742,997,600 |
| Earnings Timestamp | 1,774,528,200 |
| Earnings Timestamp End | 1,779,885,000 |
| Earnings Timestamp Start | 1,779,885,000 |
| Ebitda | -10,571,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.227 |
| Enterprise To Revenue | 1.013 |
| Enterprise Value | 2,401,200 |
| Eps Forward | -0.39 |
| Eps Trailing Twelve Months | -0.94 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 972 73 232 5602 |
| Fifty Day Average | 0.571 |
| Fifty Day Average Change | -0.21399999 |
| Fifty Day Average Change Percent | -0.37478107 |
| Fifty Two Week Change Percent | -84.80851 |
| Fifty Two Week High | 4.98 |
| Fifty Two Week High Change | -4.623 |
| Fifty Two Week High Change Percent | -0.92831326 |
| Fifty Two Week Low | 0.271 |
| Fifty Two Week Low Change | 0.085999995 |
| Fifty Two Week Low Change Percent | 0.31734315 |
| Fifty Two Week Range | 0.271 - 4.98 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,517,409,000,000 |
| Float Shares | 10,134,556 |
| Forward Eps | -0.39 |
| Forward P E | -0.91538465 |
| Free Cashflow | -5,480,875 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 39 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.64782995 |
| Gross Profits | 1,536,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.26884001 |
| Held Percent Institutions | 0.10998 |
| Implied Shares Outstanding | 14,415,128 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. The company's products are based on its recombinant human collagen (rhCollagen) that is produced using its proprietary technology. It offers regenerative dermal and soft tissue fillers; 3D-bioprinted regenerative breast implants; VergenixSTR, a soft tissue matrix for the treatment of tendinopathy; and VergenixFG, a wound healing flowable gel for the treatment of chronic and acute wounds. The company also provides rhcollagen-based commercial bioink for regenerative medicine applications, such as Collink.3D 50L, a bioink in powder form; Collink.3D 90, an rhCollagen-based bioink solution for use in various 3D bioprinting applications; and Collink.3D 50, an rhCollagen-based bioink product. It has collaboration agreements with AbbVie; STEMCELL; the Advanced Regenerative Manufacturing Institute; Stratasys; and RegenMed Development Organization. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel. |
| Long Name | CollPlant Biotechnologies Ltd. |
| Market | us_market |
| Market Cap | 5,146,200 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_25715728 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -11,489,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 5,170,706 |
| Open | 0.3453 |
| Operating Cashflow | -9,419,000 |
| Operating Margins | -52.5 |
| Payout Ratio | 0.0 |
| Phone | 972 73 232 5600 |
| Post Market Change | 0.003000021 |
| Post Market Change Percent | 0.84034204 |
| Post Market Price | 0.36 |
| Post Market Time | 1,776,463,510 |
| Previous Close | 0.3523 |
| Price Hint | 4 |
| Price To Book | 0.7515789 |
| Price To Sales Trailing12 Months | 2.1704767 |
| Profit Margins | 0.0 |
| Quick Ratio | 2.176 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | hold |
| Recommendation Mean | 3.0 |
| Region | US |
| Regular Market Change | 0.00470001 |
| Regular Market Change Percent | 1.33409 |
| Regular Market Day High | 0.4138 |
| Regular Market Day Low | 0.3301 |
| Regular Market Day Range | 0.3301 - 0.4138 |
| Regular Market Open | 0.3453 |
| Regular Market Previous Close | 0.3523 |
| Regular Market Price | 0.357 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 396,826 |
| Return On Assets | -0.48665002 |
| Return On Equity | -1.17559 |
| Revenue Growth | -0.634 |
| Revenue Per Share | 0.194 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 14,415,128 |
| Shares Percent Shares Out | 0.0043 |
| Shares Short | 62,082 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 75,852 |
| Short Name | CollPlant Biotechnologies Ltd. |
| Short Percent Of Float | 0.0058999998 |
| Short Ratio | 1.86 |
| Source Interval | 15 |
| Symbol | CLGN |
| Total Cash | 5,591,000 |
| Total Cash Per Share | 0.388 |
| Total Debt | 2,846,000 |
| Total Revenue | 2,371,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.94 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.741815 |
| Two Hundred Day Average Change | -1.384815 |
| Two Hundred Day Average Change Percent | -0.7950414 |
| Type Disp | Equity |
| Volume | 396,826 |
| Website | https://collplant.com |
| Zip | 7,670,104 |